News Lipum AB

Equities

Market Closed - Nasdaq Stockholm Other stock markets 10:53:36 2024-05-17 EDT			5-day change	1st Jan Change
6.5 ^SEK	-1.52%		-0.76%	-0.31%

05-06	Lipum Obtains SEK20 Million Loan from Flerie Invest	MT
04-02	Lipum Strengthens Its Protection of the Drug Candidate Sol-116 Through A Patent Application for Inflammation-Driven Cancer	CI

BioStock: Flerie Invest continues to support Lipum	05-13	AQ
Lipum Obtains SEK20 Million Loan from Flerie Invest	05-06	MT
Lipum receives loan commitment of SEK 20 million	05-06	AQ
BioStock: Lipum's CEO looks ahead after the rights issue	04-26	AQ
Lipum announces final outcome of the rights issue	04-25	AQ
Lipum - Financed and ready to go	04-24	AQ
Lipum announces preliminary outcome of the rights issue	04-23	AQ
Lipum and NorthX Biologics enter into new strategic manufacturing alliance	04-18	AQ
Lipum has been granted funding from Swelife	04-12	AQ
Lipum publishes supplement to the prospectus regarding the rights issue	04-05	AQ
Lipum publishes prospectus regarding the rights issue	04-03	AQ
BioStock: Lipum seeks patent protecting inflammation-driven cancer treatment	04-03	AQ
Lipum AB - Report from the Extraordinary General Meeting	04-02	AQ
Lipum strengthens its protection of the drug candidate SOL-116 through a patent application for inflammation-driven cancer	04-02	AQ
Lipum Strengthens Its Protection of the Drug Candidate Sol-116 Through A Patent Application for Inflammation-Driven Cancer	04-02	CI
BioStock: Lipum has included first RA patient	03-22	AQ
Statement from the Board of Directors of Lipum regarding the mandatory public offer from Flerie Invest AB	03-20	AQ
Flerie Invest AB cancelled the acquisition of remaining 67.99% stake in Lipum AB (OM:LIPUM).	03-19	CI
Lipum Recommends Shareholders to Not Accept Mandatory Cash Offer	03-19	CI
LIPUM REPORTS FIRST PATIENT INCLUDED IN THE ONGOING PHASE I CLINICAL STUDY WITH SOL-116	03-19	AQ

No results for this search